Learn and gain detailed insights into Monolith X, Andromeda X, and Prometheus Panta.
Experience these technologies first-hand by testing samples during the hands-on session.
Discuss your own projects with experts and discover how scientists in your area have implemented the technologies successfully in their research.
Introduction from Merck KGaA
Dr. Ansgar Wegener & Dr. Nina Grossmann, Merck Healthcare KGaA
Introduction from NanoTemper Technologies
Dr. Gianluca Russo, Account Manager, NanoTemper Technologies
Unraveling Protein Stability: A Journey from Expression to Advanced Biophysical Analysis Using Andromeda X and Prometheus Panta
Dr. Ping Zhang, Field Application Scientist, NanoTemper Technologies
From Screening to Validation: Exploring Biomolecular Interactions with Spectral Shift Technology
Dr. Gianluca Russo, Account Manager, NanoTemper Technologies
Coffee Break
Utilization of Nano Differential Scanning Fluorimetry as an Efficient Tool for Routine Thermal Stability Assessment of Monoclonal Antibodies and Antibody-Drug Conjugates
Dr. Jason Tonillo, Lab Head of ADC Analytics, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA
Characterization of binary & ternary PROTAC complexes in solution using Monolith X
Dr. Fiona Sorrell, Lab Head, Structural Biology & Biophysics, Discovery Pharmacology, Merck Healthcare KGaA
TBD
Dr. Can Araman, Senior Manager Protein Formulation Laboratory - Liquid Formulation R&D Life Science, Process Solutions, Upstream & Process Materials R&D, Merck Healthcare KGaA
Lunch break
(optional)
Measurements of samples for pre-registered attendees
(optional)
Anyone working in the field of biological research dealing with proteins and biomolecular interactions.
二月 19, 2025
Merck KGaA
Darmstadt, Germany